New Product Approved from Pfizer

I am pleased to inform you that Pfizer announced the approval of MYLOTARG® (gemtuzumab ozogamicin) Injection for IV infusion on September 1st,  2017. The following information is for State Society review:

Approval Information: http://www.pfizer.com/news/press-release/press-release-detail/pfizer_receives_fda_approval_for_mylotarg_gemtuzumab_ozogamicin

Prescribing Information: click here